95
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1

, , , , , , , , , , & show all
Pages 219-226 | Published online: 14 Jan 2019

References

  • BrookJDMcCurrachMEHarleyHGMolecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family memberCell19926847998081310900
  • HarperPMyotonic Dystrophy2nd edOxfordOxford University Press2009
  • BarcelóJMMahadevanMSTsilfidisCMacKenzieAEKornelukRGIntergenerational stability of the myotonic dystrophy protomutationHum Mol Genet1993267057098353489
  • TsilfidisCMacKenzieAEMettlerGBarcelóJKornelukRGCorrelation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophyNat Genet1992131921951303233
  • DoiYIntroduction – conceptual issues on quality of life (QOL) and importance of QOL researchJ Natl Instit Public Health2004533176180
  • GrahamCDRoseMRGrunfeldEAKyleSDWeinmanJA systematic review of quality of life in adults with muscle diseaseJ Neurol201125891581159221597956
  • AntoniniGSosciaFGiubileiFHealth-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioningJ Rehabil Med200638318118516702085
  • FujinoHShingakiHSuwazonoSCognitive impairment and quality of life in patients with myotonic dystrophy type 1Muscle Nerve201857574274829193182
  • LabergeLMathieuJAuclairJGagnonÉNoreauLGagnonCClinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patientsEur Neurol2013705–630831524158106
  • KawaiMOnoMYatabeKOhyaYSaitoTSugiyamaHDevelopment of MDQoL-60 for Patients with Muscular Dystrophy [Kainyuu no koukahantei no tameno kinnjisutorofi-QOL hyouka shakudo MDQoL-60 no kaihatsu]Hasuda, SaitamaHigashisaitama National Hospital2005
  • PericSVujnicMDobricicVFive-year study of quality of life in myotonic dystrophyActa Neurol Scand2016134534635127696366
  • FukuharaSBitoSGreenJHsiaoAKurokawaKTranslation, adaptation, and validation of the SF-36 Health Survey for use in JapanJ Clin Epidemiol19985111103710449817121
  • FukuharaSWareJEJrKosinskiMWadaSGandekBPsychometric and clinical tests of validity of the Japanese SF-36 Health SurveyJ Clin Epidemiol19985111104510539817122
  • WareJEGandekBGuyerRDengNStandardizing disease-specific quality of life measures across multiple chronic conditions: development and initial evaluation of the QOL Disease Impact Scale (QDIS®)Health Qual Life Outcomes20161418427255462
  • MahoneyFIBarthelDWFunctional evaluation: the Barthel indexMd State Med J1965146165
  • RadloffLThe CES-D Scale: a self-report depression scale for research in the general populationAppl Psychol Meas197713385401
  • ShimaSShikanoTKitamuraTAtarashii yokuutsusei no jikohyouka shakudo ni tsuite [New self-reporting scale on depression]Seishin Igaku198527717723
  • TakegamiMSuzukamoYWakitaTDevelopment of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theorySleep Med200910555656518824408
  • FukuharaSSuzukamoYManual of SF-36v2 Japanese version3rd ed2004KyotoiHope International Inc.2015
  • TielemanAAJenksKMKalkmanJSBormGvan EngelenBGMHigh disease impact of myotonic dystrophy type 2 on physical and mental functioningJ Neurol2011258101820182621461958
  • PericSStojanovicVRBastaIInfluence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1Clin Neurol Neurosurg2013115327027522695270
  • KalkmanJSSchillingsMLvan der WerfSPExperienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-IJ Neurol Neurosurg Psychiatr2005761014061409
  • SprangersMASchwartzCEIntegrating response shift into health-related quality of life research: a theoretical modelSoc Sci Med199948111507151510400253
  • BaldanziSBevilacquaFLorioRDisease awareness in myotonic dystrophy type 1: an observational cross-sectional studyOrphanet J Rare Dis2016113427044540
  • OkkersenKBuskesMGroenewoudJThe cognitive profile of myotonic dystrophy type 1: a systematic review and meta-analysisCortex20179514315528892766
  • De AntonioMDoganCHamrounDUnravelling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study with implications for disease classificationRev Neurol20161721057258027665240
  • BrumbackRACarlsonKMThe depression of myotonic dystrophy: response to imipramineJ Neurol Neurosurg Psychiatry19834665875886875601
  • DuveneckMJPortwoodMMWicksJJLiebermanJSDepression in myotonic muscular dystrophyArch Phys Med Rehabil198667128758773800615
  • GallaisBMontreuilMGargiuloMEymardBGagnonCLabergeLPrevalence and correlates of apathy in myotonic dystrophy type 1BMC Neurol20151514826296336
  • WinbladSJensenCMånssonJESamuelssonLLindbergCDepression in myotonic dystrophy type 1: clinical and neuronal correlatesBehav Brain Funct2010612520482818
  • BungenerCJouventRDelaporteCPsychopathological and emotional deficits in myotonic dystrophyJ Neurol Neurosurg Psychiatry19986533533569728948
  • StarksteinSEMaybergHSPreziosiTJAndrezejewskiPLeiguardaRRobinsonRGReliability, validity, and clinical correlates of apathy in Parkinson’s diseaseJ Neuropsychiatry Clin Neurosci1992421341391627973
  • JohnsMThe official website of the Epworth Sleepiness Scale (ESS) and the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) Available from: http://epworthsleepinessscale.com/about-the-ess/Accessed December 20, 2018
  • BonanniECarnicelliLCrapanzanoDDisruption of sleep-wake continuum in myotonic dystrophy type 1: beyond conventional sleep stagingNeuromuscul Disord201828541442129631952
  • LabergeLDauvilliersYBéginPRicherLJeanSMathieuJFatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?Neuromuscul Disord200919639740219403309
  • HeatwoleCBodeRJohnsonNPatient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)Neurology201279434835722786587
  • KierkegaardMHarms-RingdahlKWidén HolmqvistLTollbäckAPerceived functioning and disability in adults with myotonic dystrophy type 1: a survey according to the International Classification of Functioning, Disability and HealthJ Rehabil Med200941751252019543661
  • LabergeLGagnonCDauvilliersYDaytime sleepiness and myotonic dystrophyCurr Neurol Neurosci Rep201313434023430686
  • van HiltenJJKerkhofGAvan DijkJGDunnewoldRWintzenARDisruption of sleep-wake rhythmicity and daytime sleepiness in myotonic dystrophyJ Neurol Sci1993114168758433100
  • PericSHeatwoleCDurovicEProspective measurement of quality of life in myotonic dystrophy type 1Acta Neurol Scand2017136669469728660733
  • HeatwoleCJohnsonNDekdebrunJMyotonic dystrophy patient preferences in patient-reported outcome measuresMuscle Nerve Epub2018112
  • Moss-MorrisRAdjusting to chronic illness: time for a unified theoryBr J Health Psychol201318468168624118260
  • OkkersenKJimenez-MorenoCWenningerSCognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trialLancet Neurol201817867168029934199